Demand-Led Clinical Supply Model for Program-level Product Pooling in Global Decentralized Study

Key Takeaways

Personalized treatment strategies are crucial in managing lung cancer brain metastases, enhancing patient outcomes through targeted therapies and immunotherapies.
Stereotactic radiosurgery and whole-brain radiation therapy continue to play vital roles, adapting to new systemic treatment advancements.
Multidisciplinary collaboration among oncologists, neurosurgeons, and radiation specialists is essential for optimizing patient care and tailoring interventions.

Global decentralized trials require fast, efficient, and sustainable clinical supply solutions. This case study shows how a biopharma company worked with Catalent’s FastChain® demand-led model to improve supply by reducing waste and shipments by 40%, speeding patient dosing to under three weeks, and enabling flexible, decentralized packaging and distribution, whilst supporting an eco-friendly trial management worldwide.

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content